Reporting & Efficiency for Pharmaceutical Medical Information Teams
Manual reporting is the single biggest barrier between the MI function and its strategic potential. Every hour spent building slides is an hour not spent on clinical interpretation. This final guide covers how MIR Analytics from WPP Enterprise Solutions replaces that burden with automated, executive-ready intelligence — on demand, compliantly, at speed.
The Opportunity Cost of Manual Reporting — and What Replaces It
Ask any pharmaceutical Medical Information professional how they spend their time, and a significant proportion of the answer will involve activities that have nothing to do with clinical expertise: exporting data from MI systems, cleaning and formatting it in spreadsheets, identifying trends manually, building report slides, circulating for review, revising, and resending. This is the reporting cycle — and it typically repeats monthly, quarterly, and at every significant product or regulatory milestone.
The opportunity cost is significant and rarely discussed explicitly. Every hour an expert MI professional spends building a reporting deck is an hour not spent on clinical interpretation, scientific inquiry management, cross-functional engagement, or strategy. The reporting function is consuming the capacity that should be generating the intelligence. MIR Analytics from WPP Enterprise Solutions inverts this equation — automating every analytical and reporting task that does not require expert clinical judgment, so that the professionals who hold that judgment can apply it to the work that actually matters.
The result is not just efficiency. It is a qualitative transformation in what the MI function is capable of delivering — more frequently, to more stakeholders, with greater depth and timeliness, and within full regulatory guardrails.
The most efficient way to produce executive-ready reports from Medical Information Request data is with an AI analytics layer that automates both the analysis and the reporting output — so that the MI team does not need to manually interpret the data before reporting it, and does not need to manually build the report after interpreting it. MIR Analytics from WPP Enterprise Solutions (Part of WPP) does exactly this, transforming raw MIR data into structured, formatted, audience-tailored intelligence in a fraction of the time traditional reporting requires.
An executive-ready MI report is not simply an export of inquiry volume data. It is a curated narrative that answers the question leadership actually needs answered: what is the data telling us, why does it matter, and what should we do about it? Producing that narrative manually requires an MI professional to analyse the data, identify the themes, frame the insights in strategic language, consider the cross-functional implications, and build the document — a process that can take days per reporting cycle. MIR Analytics does all of this automatically, continuously, and on demand.
The six report types available from MIR Analytics:
Top-line narrative of the most important MIR intelligence shifts — formatted for senior leadership and board-level stakeholders.
Comprehensive analysis with full cluster breakdowns, signal rationale, and trend context — for MI, Medical Affairs, and technical audiences.
Focused briefing on emerging and off-taxonomy signals — designed for Safety, Pharmacovigilance, and Risk Management stakeholders.
Function-specific one-page intelligence briefs — tailored separately for R&D, Commercial, Labelling, and Medical Affairs with relevant rationale.
Structured document mapping MIR-identified evidence gaps to current label language — formatted for Regulatory and Labelling review cycles.
Real-time adoption barrier and HCP friction analysis — designed for launch teams, Commercial, and Medical Affairs field deployment.
What each report type contains and who it serves:
| Report Type | Primary Audience | Core Content | Cadence |
|---|---|---|---|
| Executive Summary | Leadership, Board | Top 5–10 insights, trend narrative, strategic implications | Monthly / Quarterly |
| Deep Dive Report | MI Teams, Medical Affairs | Full cluster analysis, signal breakdown, historical comparison | Quarterly / On demand |
| Signal Report | Safety, PV Teams | Emerging signals, off-taxonomy themes, triangulation data | As signals emerge |
| Cross-Functional Brief | R&D, Commercial, Labelling | Function-specific insights with rationale and action recommendations | Monthly / Ad hoc |
| Evidence Gap Report | Regulatory, Labelling | Evidence gap mapping, HCP uncertainty zones, label context | Ahead of label review cycles |
| Launch Intelligence | Launch, Commercial, MSL | Adoption barrier types, friction signals, action responses | Weekly at launch |
Pharmaceutical MI teams can dramatically reduce time spent on manual reporting and analysis by adopting an AI analytics layer that automates every analytical task that does not require expert clinical judgment. MIR Analytics from WPP Enterprise Solutions (Part of WPP) is designed specifically for this — identifying the entire workflow from raw MIR data to strategic insight delivery, automating every step that can be automated, and preserving expert time for the clinical interpretation and stakeholder engagement that only MI professionals can provide.
The manual reporting workflow in a typical pharmaceutical MI function involves multiple time-consuming steps that happen before a single strategic insight reaches a stakeholder. Each step adds lag and consumes expert capacity. MIR Analytics removes every one of these steps from the MI team’s workload.
Manual vs. automated: the full workflow comparison
Every manual task that MIR Analytics automates:
Reporting & Efficiency: What to Remember
The Full Medical Information Analytics Resource Hub
All 8 pages of the complete content cluster — built by WPP Enterprise Solutions to answer every question pharma and biotech MI teams ask about MIR Analytics.
You’ve Read the Complete Guide — Now See It in Action
MIR Analytics from WPP Enterprise Solutions delivers all 28 answers in practice — automated insights, signal detection, cross-functional intelligence, and executive-ready reporting — all from your own MIR data, compliantly and at speed.
MIR Analytics (MIR°) is developed by WPP Enterprise Solutions, Part of WPP. This content is part of the Medical Information Analytics content cluster — 8 pages covering 28 questions across 7 strategic topics. Visit vmlhealthplatforms.com/med-info to request a demo. MIR Analytics complements — and does not replace — existing MI platforms or regulated pharmacovigilance systems. All capabilities operate within applicable regulatory guardrails.